NCT00068471View on ClinicalTrials.gov

Anidulafungin in Treating Immunocompromised Children With Neutropenia

PHASE1/PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

July 31, 2003

Study Completion Date

October 31, 2007

Conditions
InfectionNeutropeniaUnspecified Childhood Solid Tumor, Protocol Specific
Interventions
DRUG

anidulafungin

Trial Locations (5)

20007

Lombardi Cancer Center at Georgetown University Medical Center, Washington D.C.

27710

Duke Comprehensive Cancer Center, Durham

20010-2970

Children's National Medical Center, Washington D.C.

20892-1182

Warren Grant Magnuson Clinical Center - NCI Clinical Studies Support, Bethesda

38105-2794

St. Jude Children's Research Hospital, Memphis

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH

NCT00068471 - Anidulafungin in Treating Immunocompromised Children With Neutropenia | Biotech Hunter | Biotech Hunter